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aneurysms
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Anthony G. Verstandig, MB, BS,b and Oded Olsha, MB, BS,a Jerusalem, Israel
Background: Aneurysms that develop in arteriovenous accesses as a result of repeated punctures are sometimes compli-
cated by infection or ischemia causing sloughing of the overlying skin, which may endanger the access and risk major
bleeding and other complications. Surgical revision may necessitate the temporary use of a central venous catheter until
dialysis can be resumed via the access. We used stent grafts in selected patients for the exclusion of access aneurysms.
Methods: Twenty of 63 patients requiring access revision for complication of an aneurysm from February 2005 to
December 2009 underwent ambulatory endovascular stent graft deployment. Indications included signs of impending
rupture, questionable viability of overlying skin, pain, infection, and limitation of cannulation sites by the size or number
of the aneurysms. Endovascular treatment always included angioplasty of associated outflow or central vein stenoses at
the same ambulatory session.
Results: Twenty patients with complicated access aneurysms were treated by endovascular stent graft exclusion at an
average of 4.8  4.3 years (range, 0.2 to 16.1 years) after access construction: nine graft pseudoaneurysms, nine native
vein aneurysms, and two acute iatrogenic pseudoaneurysms. Six patients had skin erosion over the aneurysm, and 12 had
painful aneurysms and clinical signs of compromised blood supply to the skin. Another two patients with an acute giant
false aneurysm occurring during endovascular procedures were treated in the same interventional session by the stenting
technique to control bleeding. All the aneurysms underwent endovascular exclusion without complications. Only one
infected puncture site failed to heal within 2 months of stenting and was closed surgically 10 months later due to
persistent localized graft infection, but with no further bleeding episodes. Only one aneurysm did not reabsorb within 3
months. Patients with painful skin ischemia had immediate pain relief. All patients also had stenosis in the draining veins
necessitating additional percutaneous transluminal angioplasty. Only one patient required hospitalization (for intrave-
nous antibiotic treatment of staphylococcal sepsis). No patients required a central catheter for hemodialysis. One access
occluded due to cephalic arch stenosis in a noncompliant patient. Functional patency was 87% at 12 months, with a
median follow-up of 15 months (range, 6.3 to 55.5 months).
Conclusion: Endovascular treatment with stent grafts in complicated access aneurysms is a simple, safe and rapid ambulatory
procedure that enables treatment of both the aneurysm and its accompanying draining vein stenosis. It enables continued
cannulation of the existing access and avoids the use of central catheters. (J Vasc Surg 2011;54:1088-94.)
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MAneurysms in hemodialysis accesses pose a special prob-
lem when they endanger the life of the access and some-
times directly endanger the life of the patient, be it a native
fistula or a graft. Progressive enlargement of aneurysms
compromises the overlying skin and repeated puncture can
subsequently be complicated by ischemia or infection. This
can lead to sloughing and rupture with exsanguinating
hemorrhage that can cause death (Fig 1). In addition, large
aneurysms can prevent access to the adjacent fistula for
needle placement, thus limiting available cannulation re-
gions.1 Their presence has the potential to shorten the life
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1088f the fistula, leading to a reduction in “venous capital” for
reating new fistulas.
The introduction of endovascular therapy has heralded
new era in the field of vascular access surgery. The
ndovascular approach is gradually reducing the require-
ent for surgical revision. Endovascular procedures like
hrombolysis, therapeutic angioplasty with or without
tenting, and preemptive angioplasty will extend the lon-
evity of most vascular accesses beyond previous expecta-
ions.2 Furthermore, advances in medical therapy and renal
eplacement therapy have increased the longevity of the
verage dialysis patient.3 Problems like aneurysm forma-
ion, that were relatively uncommon in the past, have
onsequently become more frequent and challenging. Sur-
ical treatment may require excision of the aneurysm and
ften involves bypass grafting around the aneurysm. In
ddition, temporary use of a central venous catheter is
requently necessary after surgical treatment. We describe
ur experience with endovascular treatment of access aneu-
ysms that require intervention.
ETHODS
Our Access Center is a regional referral center in Jeru-
alem, Israel. We construct approximately 300 new arterio-
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procedures annually. We supply vascular access services to
many hemodialysis units in Israel. All patients are followed
and data are recorded in a prospective database that is
separate from and additional to the hospital medical re-
cords. From February 2005 to December 2009, we treated
63 patients for access aneurysm-related complications. For-
ty-three patients had surgical revision. This observational
study comprises the 20 patients presenting with access
aneurysm-related complications who were treated by stent-
ing. No patients undergoing endovascular treatment for
access aneurysms were excluded from this study.
Indications for intervention. The indications for in-
tervention were signs of impending rupture such as rapid
increase in size of the aneurysm, poor eschar formation over
the puncture site, spontaneous bleeding or difficulty in
achieving hemostasis at the conclusion of the hemodialysis
session, and various other indications such as questionable
viability of the skin over the aneurysm due to thinning,
symptomatic aneurysms (pain), local infection, or limita-
tion of cannulation sites by the size or number of the
aneurysms.1,4,5 Revisions were not done for esthetic rea-
sons for access aneurysms that did not fulfill the recom-
mended criteria for revision.
Preoperative assessment. In our center, all access pa-
tients enter our routine access surveillance program.6,7 For
autogenous access, the patients are examined clinically and
with color-coded Doppler ultrasound imaging (Acuson
Sequoia 512 [Mountain View, Calif] with a 6L3 multifre-
quency linear array transducer, which was replaced by a
Philips iU22 [Bothell, Wash] with an L9-3 broad-spectrum
linear array transducer in 2008). Examinations are done at
1, 6, and 12 months, and then every 12 months as long as
no problems are identified by Doppler ultrasound or by the
dialysis units. A rise in dialysis pressures with a drop in
Fig 1. A 75-year-old woman with brachial cephalic autogenous
access with acute puncture site bleeding referred from another
hospital for urgent treatment. The aneurysm with overlying eschar
through which the patient bled is clearly visible.dialysis dose delivery (Kt/V or urea reduction ratio) may vndicate impending access failure8 requiring maintenance
ngioplasty. Prosthetic accesses are examined every 3
onths, or if referred by the dialysis units. Surveillance
ncludes examination of the puncture sites, measuring flow,
nd assessing the outflow vessels.
All preoperative and follow-up Doppler ultrasound ex-
minations in our access center are performed by one of the
wo dedicated access surgeons (D.S., I.G.). Patients were
xamined lying supine with the head raised to 30° and with
he arm abducted to 30° to 45°. Examination included
lood flow measurement, direct examination of the anas-
omosis, and examination of the entire length of the vein or
raft, with display of the draining vein, the confluence with
he subclavian vein, and the proximal innominate vein
hen technically possible. When the clinical findings indi-
ated the necessity for revision, the assessment included
easurement of the diameter of the aneurysm neck and the
ength of the stent needed to exclude the aneurysm and to
ermit a 1 cm seal zone for the stent at each end. These
easurements enabled us to tailor the stent size and length
o be used in advance of the procedure. The entry site was
lso planned at the preoperative Doppler ultrasound exam-
nation. In autogenous accesses, this was in a portion of the
ein with a large diameter that had matured sufficiently to
ontain the large diameter of introducer sheath. In both
rosthetic and autogenous accesses, this was at a distance
rom the aneurysm that was sufficient to comfortably de-
loy the stent. Another factor that was taken into account
uring planning was to leave sufficient space for puncturing
o allow hemodialysis to continue via the access since the
neurysm was not routinely resected and might take
onths to be absorbed. For this reason, in cases where
here was more than one single aneurysm, only the symp-
omatic one was treated in order to preserve availability of
uncture sites after the revision.
Exclusion of patients from endovascular treatment.
atients with overt graft infection (as opposed to infection
imited to the skin overlying the aneurysm) were not con-
idered to be candidates for stenting. Patients with steal
yndrome who required a surgical procedure had surgical
reatment of the aneurysm at the same operation. Patients
hose aneurysm was very close to the anastomosis also had
urgical repair for fear of protrusion of the stent graft into
he artery. Lack of a seal zone for the stent would obviously
xclude the patient from endovascular treatment.
Endovascular technique. Antegrade puncture of the
ccess was the preferred approach, allowing convenient
maging of the aneurysm and treatment of outflow steno-
es. It was performed in the access near the arterial anasto-
osis, preferably at the arterial hemodialysis puncture site
o allow placement of a large introducer sheath when
ecessary. If the aneurysm was close to the arterial side, a
etrograde approach was used, but this required a separate
uncture for treatment of outflow stenoses. The access and
ts entire venous drainage were imaged before treating the
neurysm and any associated significant outflow or central
ein stenoses.
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October 20111090 Shemesh et alAfter injection of local anesthesia, puncture was per-
formed with an 18-gauge needle (Biometrix Inc, Jerusa-
lem, Israel), and a guidewire was advanced into the access.
An introducer sheath (Avanti; Cordis Corporation, Bridge-
water, NJ and Cook Inc, Bloomington, Ind) ranging from
8F to 12F (of sufficient size to contain the stent graft) was
inserted over the wire. Multiple projections with digital
subtraction angiography were used where necessary to pre-
cisely define the proximal and distal aneurysm necks. Stent
diameter and length were based on measurements made at
preprocedureDoppler ultrasound and correlated withmea-
surements made at the time of angiography. Stents were
chosen with a diameter 1mm larger than the normal vein or
graft adjacent to the aneurysm. If there was a difference in
the vein diameter on either side of an aneurysm, the stent
size was based on the larger diameter. The stent length was
selected in order to exclude the aneurysm and cover at least
1 cm of normal vein or graft on either side. At this stage, a
4000 IU bolus of heparin was injected and 1 to 2 mg of
midazolam was administered for sedation. Crossing the
aneurysm was performed with a floppy tip Bentson guide-
wire (Cook Inc) and a Berenstein or hockey stick catheter
(Angiodynamics Inc, Queensbury, NY), or Radifocus hy-
drophilic guidewire (Terumo Corp, Tokyo, Japan).
Before treating the aneurysm, significant outflow or
central vein stenoses were dilated using a 4 cm long high
pressure (25-30 atm) balloon dilatation catheter (Bard
Peripheral Vascular, Tempe, Ariz). Balloon diameter was
determined by visually estimating the diameter of the non-
stenosed outflow or central vein adjacent to the focal area of
narrowing. The balloon was inflated to the point of resolu-
tion of the waist up to the maximum rated pressure. The
Bentson wire was replaced by a 180 cm Amplatz extra stiff
wire (Cook Inc). The Hemobahn requires a 0.025 inch
diameter wire, and the Viabahn and Fluency Plus, 0.035
inch.
Stent selection for the procedure was influenced by the
location of the lesion. In grafts, where the risk of in segment
stenosis was low and if the aneurysm was located in a
straight segment, a Fluency Plus stent graft (Bard Periph-
eral Vascular) was used in order to reduce costs. In autog-
enous accesses, we preferred the Viabahn or Hemobahn
(W. L. Gore & Associates, Flagstaff, Ariz) over the Fluency
Plus to reduce the potential for in-segment stenosis.6 If
there was a difference in vein diameter on either side of the
aneurysm of more than 2 mm, we used a Fluency Plus stent
graft because it is stiffer, and oversizing of the softer Via-
bahn or Hemobahn may result in infolding of the stent
graft with failure of aneurysm exclusion or compromise of
blood flow. After stent deployment, low-pressure balloon
dilatation to a diameter of 1 mm less than the graft size was
performed. Repeat angiography was used to confirm exclu-
sion of the aneurysm. The sheath was removed after place-
ment of a purse string suture for hemostasis.
Acute, symptomatic, enlarging false aneurysms compli-
cating endovascular interventions required accurate stent
graft placement for false aneurysm exclusion and treatment
of the associated outflow or central venous stenosis. Inflow wontrol by the assistant to allow rapid sheath upsizing and
tent delivery was achieved bymanual digital pressure at the
rteriovenous anastomosis during the exchange. This
locked the inflow to the vein, thereby preventing further
leeding and aneurysm enlargement.
The first stent graft inserted in our access center was the
allgraft (Boston Scientific, Natick, Mass). The Wallgraft
ndoprosthesis was subsequently not used as it was with-
rawn from the Israeli market. Thereafter we used the
luency Plus in 13 patients, the Viabahn or Hemobahn in
n additional five patients, and in one patient, a Hemobahn
as extended with a Fluency Plus stent.
Specific circumstances may dictate technical modifica-
ion in each individual case.9 As the stent limits further vein
ilatation while the autogenous access matures, the maxi-
um-sized stent possible was used. All procedures were
erformed as day cases except for a 9-year-old child who
as admitted for treatment with intravenous antibiotics
ecause of S aureus bacteremia.
Post intervention hemodialysis and follow-up.
atients were returned to their respective dialysis units for
ontinued hemodialysis using the existing access. If there
as a subsequent need to use the stent site for puncture,
his could be carried out once the aneurysm sac was reab-
orbed.
All patients re-entered the surveillance program. Both
utogenous and prosthetic accesses were examined every 3
onths as described above. Patients were examined for
ealing of ulcerations, resorption of the aneurysm, patency
f the access, and the need for fistulography and angio-
lasty.
ESULTS
We examined the outcome of endovascular manage-
ent in 20 successive patients from February 2005 to
ecember 2009 for patency and functionality of the access,
elief of symptoms, and healing of skin ulceration where
pplicable.
Patient characteristics are shown in Table I. Ten were
emales, and 10 were males. The average age at the time of
ccess construction was 61  22 years (range, 5-89 years),
nd the average age at the time of endovascular revision was
5  20 years (range, 9-90 years). There were five diabet-
cs, four with hypertensive renal failure, three patients with
ystemic lupus erythematosus, two idiopathic, and one each
ith hemolytic-uremic syndrome, nephrotic syndrome,
lomerulonephritis, polycystic kidney disease, renal artery
tenosis, and hyperparathyroidism as the cause of their renal
ailure.
There were nine graft access pseudoaneurysms (three
orearm grafts) and 11 native vein access aneurysms and
seudoaneurysms (one forearm fistula). There were six
atients with skin erosion over the aneurysm (two in grafts
nd four in native accesses), and 12 patients with painful
neurysms and clinical signs of compromised blood supply
o the skin. All patients with erosions were assumed to have
nfection. Patients with autogenous accesses were treated
ith prophylactic antibiotics at surgery. Patients with grafts
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therapeutic course of antibiotics for 4 weeks. Another two
patients with autogenous accesses developed an acute giant
false aneurysm during endovascular procedures and were
treated in the same interventional session by stent graft
placement to control bleeding.
The average luminal diameter of the aneurysms by
Doppler ultrasound was 3.0 0.9 cm (range, 1.2-5.0 cm),
and the average length was 4.3  1.4 cm (range, 2.6-6.7
cm). The time from access construction to endovascular
revision for the aneurysm was 4.8  4.3 years (range,
0.2-16.1 years).
Results of stenting are shown in Table II. Endovascular
exclusion of the aneurysms was successful in all 20 patients.
In 15 patients (75%), one stent was sufficient to exclude the
aneurysm; in four patients, two stents were necessary; and
in one patient, three stents were required to completely
exclude the aneurysm. The mean follow-up was 16.8 14.1
months (median, 15 months; range, 6.3-55.5 months).
Table I. Characteristics of 20 patients who underwent
stent graft deployment to treat an access aneurysm
Age (years) at treatment (mean  SD,
range)
65  20, 9-90
Gender
Male 10
Female 10
Etiology of end-stage renal disease
Diabetes mellitus 5
Hypertension 4
Systemic lupus erythematosus 3
Other 8
Type of access
Autogenous vein 11
Prosthetic graft 9
Reason for treatment
Pain with ischemia of overlying skin 12
Nonhealing skin erosions 6
Acute painful giant false aneurysms 2
Luminal diameter (cm) of aneurysm by
Doppler ultrasound (mean  SD,
range) 3.0  0.9, 1.2-5.0
Time (years) from access construction to
treatment (mean  SD, range) 4.8  4.3, 0.2-16.1
Angioplasties per patient year before
treatment (mean  SD, range) 1.8  1.3, 0.5-4.6
Table II. Results of stent graft deployment in 20
patients treated for access aneurysm
Technical success 20 (100%)
Temporary dialysis via central catheter 0 (0%)
Number of stents per patient
Single stent 15
Two stents 4
Three stents 1
Median follow up in months (range) 15 (6-56)
Angioplasties per patient year after
treatment (mean  SD, range) 1.4  1.2, 0-3.8
Functional patency at 12 months 87%Eight patients (40%) died during the follow-up period. ane access thrombosed 5.6 months after aneurysm exclu-
ion probably due to recurrent outflow stenosis for which
he patient had refused treatment. One prosthetic access
as closed surgically 10.7 months after stenting because of
hronic infection and failure of the ulceration to heal, but
he immediate threat of acute bleeding was averted. All the
ther 19 patients (95%) had symptom resolution. The
unctional patency at 12 months was 87% (Fig 2).
In all the patients, a significant outflow or central vein
tenosis was documented and treated by angioplasty. Nine-
een of the 20 patients had previous angioplasty for these
tenoses. An average of 1.8 1.3 (range, 0-4.6) angioplas-
ies per patient year were performed for outflow or central
ein stenosis before treatment for the aneurysm. They
ontinue to undergo repeated angioplasties for outflow or
entral vein stenosis since the exclusion of their aneurysms
ith stent grafts (1.4  1.2 angioplasties per patient year;
ange, 0-3.8). The stent graft itself was subsequently used
or hemodialysis puncture in six of the patients. There was
o need for temporary catheters in any patient after endo-
ascular aneurysm exclusion.
ISCUSSION
Twenty arteriovenous access aneurysms were success-
ully treated with covered stents. Most patients required
nly one stent, but up to three stents were used to com-
letely exclude the aneurysm in our patients. All the pa-
ients had a stenosis that required angioplasty in the drain-
ng veins. The functional patency at twelve months was
7%. The only spontaneous occlusion to date in our pa-
ients was in an 89-year-old patient with an autogenous
ccess who did not present for surveillance examinations
nd maintenance therapy. Another of our patients eventu-
ig 2. Kaplan-Meier curve for endovascular exclusion of compli-
ated access aneurysms. Functional patency at twelve months was
7%. AVA, Arteriovenous access; SE, standard error.lly required closure of the graft because of persistent local
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nevertheless a very useful temporizing measure in this
patient in preventing acute bleeding through the ulcerated
skin overlying the aneurysm.
In large surgical series, interventions for correction of
access aneurysms varied between 0.8% and 6.7% of all
secondary interventions.10,11 Traditionally, arteriovenous
access aneurysms and pseudoaneurysms have been treated
most effectively by local surgical revision or by resection
and segment interposition. For graft pseudoaneurysms,
treatment has involved surgical excision or ligation and
subsequent bypass with a new graft. The goals of surgical
revision should be to eliminate the dangers posed by the
aneurysm without compromising access patency, and in-
clude treatment of the outflow or central vein stenosis that
is invariably present, while preserving puncture sites to
enable continuous efficient hemodialysis. This is important
in order to avoid the need for temporary central vein
catheters to maintain hemodialysis. Closure of the access
and creation of a new access is the simplest method of
dealing with the aneurysm, but this should only be a last
resort as it leads to a significant loss of “venous capital” and
requires the temporary use of a central vein catheter.
Giorgiadis and coworkers reported the largest series in
the literature (44 patients) with access aneurysms treated
surgically.4 Eighteen were prosthetic accesses. The aneu-
Fig 3. A Fluency stent graft was used to exclude a brach
for hemodialysis access puncture since that time. Durin
skeleton at the puncture site can be seen near the arterial
at the site of the break in the stent graft (B).rysmwas resected in 43 of the 44 patients, and interposition irafts were placed in 29. The 12-month cumulative patency
as 57% for all revisions, 69% for autogenous accesses, and
9% for prosthetic accesses. In contrast, our patients treated
y endovascular stenting had a cumulative patency at 12
onths of 87%. This difference in patency might be ex-
lained by the fact that these authors did not report on the
etection or treatment of outflow or central stenoses.
There has been a rapid increase in the use of endovas-
ular techniques in vascular surgery over the past decade,
nd this has naturally been incorporated into the manage-
ent of arteriovenous accesses. The first reported success-
ul use of a covered stent to treat a graft pseudoaneurysm
as by Sapoval in 199612 and for autogenous fistula in
002 by Allaria.13 The different types of covered stents that
ave been used in endovascular treatment have been previ-
usly described.12,14-19
Endovascular access aneurysm repair is usually per-
ormed as an outpatient procedure,20 and early dialysis
enipuncture is encouraged to return the patient to an
ninterrupted dialysis regimen.15,17 Although not specifi-
ally designed for hemodialysis needle puncture, commer-
ially available covered stent devices can endure repeated
unctures to extend the use of the access for hemodialysis
or many years (Fig 3).21,22 The most important factor in
he progression of aneurysmal dilatation is the presence of
roximal draining vein or central vein stenosis.14,21,23 Any
illary graft pseudoaneurysm 3 years earlier and was used
gioplasty for central vein stenosis, the broken Nitinol
f the stent graft (A), and there is a small false aneurysmial ax
g an
end ontervention for access aneurysm, whether surgical or en-
a
m
m
pose
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Volume 54, Number 4 Shemesh et al 1093dovascular, should include assessment for and revision of
outflow stenosis. This can be done at the same session as the
stent deployment in the endovascular setting. Failure to
treat outflow stenosis may cause an endoleak around the
Fig 4. A brachial axillary graft pseudoaneurysm was st
pseudoaneurysm sac (A), interefered with available punct
sac (C), was excised leaving the underlying stent graft exstent, aneurysm recurrence, and access failure. aEvacuation of the thrombus from the aneurysm sac
fter stent exclusion has been described mainly as a cos-
etic procedure.18,20However, if the thrombus persists for
any months before being absorbed, the stent-excluded
with a Hemobahn stent graft. The remaining 4.5 cm
ites. The organized thrombus was removed (B), and the
d (D). The overlying skin was closed in two layers (E).ented
ure sneurysm may interfere with available puncture sites. The
11
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controversial issue. We believe that surgical evacuation of
the organized aneurysm thrombus is probably the best
approach for rapid rehabilitation of an otherwise inaccessi-
ble repaired aneurysmatic puncture site (Fig 4). An incision
is made around the aneurysm, the organized hematoma is
excised, excess skin is removed, and the overlying skin is
then closed over the exposed stent as over any other graft.
It is also possible to cover the stent graft with the trimmed
wall of the pseudoaneurysm.
Stenting of access aneurysms is an additional therapeu-
tic measure to prolong the life of the hemodialysis access,
together with continuing surveillance and maintenance. It
is carried out as an outpatient procedure. The endovascular
approach enables treatment of the draining vein stenosis
and corrects the aneurysm at the same session. This tech-
nique enables continuous use of the existing access while
avoiding the use of central catheters for hemodialysis that
is frequently necessary with surgical repair. Repeated
follow-up angioplasty for outflow or central vein stenoses is
mandatory to prevent graft thrombosis and to prevent
further aneurysm formation. In our experience, the only
contraindication for endovascular treatment is in graft ac-
cess aneurysms when the graft itself (not just the skin
overlying the pseudoaneurysm) is infected.
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